Tocilizumab (Actemra)

Sheppard, M; Laskou, F; Stapleton, PP; Hadavi, S; Dasgupta, B

Sheppard, M; Dasgupta, B (reprint author), Southend Hosp, Rheumatol Dept, Westcliff On Sea SS0 0RY, Essex, England.

HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017; 13 (9): 1972

Abstract

Tocilizumab (TCZ), is a recombinant humanized anti-interleukin-6 receptor (IL-6R) monoclonal antibody which has a main use in the treatment of rheumat......

Full Text Link